Merchant API Market to reach US$119.11 billion by 2027 - Industry Trends, Growth Drivers, Key Companies and Future Opprtunities

The latest research on "Global Merchant API Market: Analysis By Molecular Type, By Segment, By Type, By Type of Synthesis, By End-User, By Region Size And Trends With Impact Of COVID-19 And Forecast up to 2027" have been added to OrbisResearch.com store.

The merchant API market refers to the use of APIs by merchants, or businesses that sell goods and services, to connect their systems and processes with those of other companies or platforms. This allows merchants to automate and streamline various aspects of their operations, such as inventory management, payment processing, and customer data management.

Request a PDF sample at https://www.orbisresearch.com/contacts/request-sample/6940231

The global merchant API market was valued at US$79.50 billion in 2021. The market value is expected to reach US$119.11 billion by 2027. The merchant API (or contract manufacturing) sits within the wider Pharma value chain and encompasses all activities related to the development and manufacture of active pharmaceutical ingredients (API) both for products clinical trials and commercial products.

There has been an increase in the willingness of, especially smaller pharma and biotech companies to collaborate with specialized entities due to the expertise and equipment required to manufacture the compounds. Additionally, pharma companies are increasingly focusing on core capabilities like R&D and marketing, leaving the manufacturing side of the process to specialized entities. Thus, merchant API market growth has increased due to increased pharma outsourcing to improve margins and potentially shorten time-to-market. The market is expected to grow at a CAGR of approx. 7% during the forecasted period of 2022-2027.

Direct purchase report at https://www.orbisresearch.com/contact/purchase-single-user/6940231

One of the key drivers of the merchant API market is the growing popularity of e-commerce and online sales. As more and more consumers turn to the internet to shop for goods and services, merchants are increasingly looking for ways to improve their online presence and reach more customers. APIs allow merchants to easily integrate their systems with those of online marketplaces, such as Amazon and Alibaba, as well as with social media platforms, such as Facebook and Instagram, to expand their reach and improve their sales.

Another driver of the merchant API market is the increasing demand for mobile commerce. As more and more consumers use their smartphones and tablets to shop online, merchants are looking for ways to make their products and services available on mobile devices. APIs allow merchants to easily create mobile apps and mobile-optimized websites that can be accessed by customers on the go.

Competitive Landscape:

The global merchant API market is highly fragmented. The key players in the global merchant API market are:

Pfizer Inc. (Pfizer CenterOne)
Bachem Holding AG
Thermo Fisher Scientific Inc.
Teva Pharmaceutical Industries Ltd. (Teva API)
Sanofi (EuroAPI)
Siegfried Holding AG
Lonza Group AG
PolyPeptide Group AG
Divi's Laboratories Limited
Centrient Pharmaceuticals
Cambrex
Fabbrica Italiana Sintetici

Browse the full report at https://www.orbisresearch.com/reports/index/global-merchant-api-market-analysis-by-molecular-type-by-segment-by-type-by-type-of-synthesis-by-end-user-by-region-size-and-trends-with-impact-of-covid-19-and-forecast-up-to-2027

To keep ahead of the competition, companies in the market undergo regular R&D operations. In order to stay ahead of the competition, companies operating on the global market are also anticipated to turn to aggressive expansion methods including mergers, acquisitions, and strategic alliances. For instance, in 2022, Bachem Group announced the signing of a further work order for the delivery of large volumes of peptides over a five-year period from 2025-2029. On the other hand, Sanofi and Innovent Biologics announced a collaboration to bring innovative medicines to patients in China with difficult-to-treat cancers. Also, Siegfried announced that the company had decided to extend the collaboration with Novavax, a US-based biopharmaceutical company, for the aseptic fill & finish of Novavax's protein-based coronavirus vaccine Nuvaxovid.

In 2021, Lonza held a share of 2.58% of the global merchant API market, whereas in CDMO market, Lonza had a market share of 4.6%.

Contact Us:
Hector Costello
Senior Manager - Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: USA: +1 (972)-591-8191 | IND: +91 895 659 5155
Email ID: sales@orbisresearch.com

About Us
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

This release was published on openPR.